Understanding the science around autoimmunity in COVID-19 will open the door to strategies that reduce the risk of severe COVID-19 and long covid. The scientific community has been slow to change direction but it comes with a cost to human lives.
This pre-print paper has found autoantibodies to angiotensin II to be significantly higher in severe COVID-19…